However, when LUS cancer does occur, it is often associated with hereditary cancer syndromes such as Lynch syndrome [7]. Considering that Lynch syndrome is more prevalent in younger patients [8], often overlapping with reproductive age, there is a clinical need to understand GnRH antagonist-induced changes in LUS cancer morphology. The gene discussed is GNRH1; the disease is Inherited cancer-predisposing syndrome.